The role of the niemann-pick disease, type c1 protein in adipocyte insulin action
The Niemann-Pick disease, type C1 (NPC1) gene encodes a transmembrane protein involved in cholesterol efflux from the lysosome. SNPs within NPC1 have been associated with obesity and type 2 diabetes, and mice heterozygous or null for NPC1 are insulin resistant. However, the molecular mechanism underpinning this association is currently undefined. This study aimed to investigate the effects of inhibiting NPC1 function on insulin action in adipocytes. Both pharmacological and genetic inhibition of NPC1 impaired insulin action. This impairment was evident at the level of insulin signalling and insulin-mediated glucose transport in the short term and decreased GLUT4 expression due to reduced liver X receptor (LXR) transcriptional activity in the long-term. These data show that cholesterol homeostasis through NPC1 plays a crucial role in maintaining insulin action at multiple levels in adipocytes.
|ISBN||1932-6203 (Electronic) 1932-6203 (Linking)|
|Authors||Fletcher, R.; Gribben, C.; Ma, X.; Burchfield, J. G.; Thomas, K. C.; Krycer, J. R.; James, D. E.; Fazakerley, D. J.;|
|Publisher Name||PLoS One|
|URL link to publisher's version||http://www.ncbi.nlm.nih.gov/pubmed/24752197|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/12340|